ASCO 2019 | Key challanges in NSCLC

David Kwiatkowski

David Kwiatkowski, MD, PhD, of the Dana-Farber Cancer Institute, Boston, MA, discusses the key challenges in resectable non-small cell lung cancer (NSCLC), and how we may treat the disease in the future. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video